Skip to content

Author

P. Hohensinner

We have 2 of 125 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Modulating atherosclerotic plaque formation by targeting plasminogen receptor PlgRKT

Macrophages are essential for atherosclerotic plaque progression. Recently a plasminogen receptor, Plg-RKT was shown to modulate monocyte and macrophage migration and lipid metabolism. However, its function on atherosclerotic development is not described yet. The aim of this study was to define the effect...

J. Kral-Pointner, L. Boccuni, M. Mussbacher et al. · 0 citations
Open access Oct 2026

Treatment with PCSK9 inhibitors reduces the expression of scavenger receptors CD16, CD36 and CD45 in patients with stable coronary artery disease and elevated Lp(a) levels

Atherosclerosis is a chronic inflammatory disease driven by dyslipidemia and activation of immune system. Scavenger receptors CD16+, CD36+ and CD45+ on peripheral blood mononuclear cells (PBMCs) are involved in foam cell formation and endothelial dysfunction, promoting atherosclerosis. Although protein convertase...

S. Ugovšek, A. R. Likozar, T. Levstek et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.